Tsao J I, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi R L, Braasch J W, Dugan J M
Department of General Surgery, Lahey Clinic Medical Center, Burlington, Massachusetts, USA.
Ann Surg. 2000 Aug;232(2):166-74. doi: 10.1097/00000658-200008000-00003.
To compare the experience and outcome in the management of hilar cholangiocarcinoma at one American and one Japanese medical center.
Controversies surround the issues of extent of resection for hilar cholangiocarcinoma and whether the histopathology of such cancers are similar between patients treated in America and in Japan.
Records were reviewed of 100 patients treated between 1980 and 1995 at the Lahey Clinic in the United States, and of 155 patients treated between 1977 and 1995 at Nagoya University Hospital in Japan. Selected pathologic slides of resected cancers were exchanged between the two institutions and reviewed for diagnostic concordance.
In the Lahey cohort, there were 25 resections, 53 cases of surgical exploration with biliary bypass or intubation, and 22 cases of percutaneous transhepatic biliary drainage or endoscopic biliary drainage without surgery. In the Nagoya cohort, the respective figures were 122, 10, and 23. The overall 5-year survival rate of all patients treated (surgical and nonsurgical) during the study periods was 7% in the Lahey cohort and 16% in the Nagoya cohort. The overall 10-year survival rates were 0% and 12%, respectively. In patients who underwent resection with negative margins, the 5- and 10-year survival rates were 43% and 0% for the Lahey cohort and 25% and 18% for the Nagoya cohort. The surgical death rate for patients undergoing resection was 4% for Lahey patients and 8% for Nagoya patients. Of the patients who underwent resection, en bloc caudate lobectomy was performed in 8% of the Lahey patients and 89% of the Nagoya patients. Histopathologic examination of resected cancers showed that the Nagoya patients had a higher stage of disease than the Lahey patients.
In both Lahey and Nagoya patients, survival was most favorable when resection of hilar cholangiocarcinoma was accomplished with margin-negative resections. Combined bile duct and liver resection with caudate lobectomy contributed to a higher margin-negative resection rate in the Nagoya cohort.
比较一家美国医疗中心和一家日本医疗中心在肝门部胆管癌治疗方面的经验及结果。
肝门部胆管癌的切除范围以及美国和日本患者的此类癌症组织病理学是否相似等问题存在争议。
回顾了1980年至1995年在美国拉希诊所接受治疗的100例患者以及1977年至1995年在日本名古屋大学医院接受治疗的155例患者的记录。两个机构交换了切除癌症的选定病理切片并进行诊断一致性审查。
在拉希队列中,有25例切除术,53例进行了胆道搭桥或插管的手术探查,22例未手术而行经皮肝穿胆道引流或内镜胆道引流。在名古屋队列中,相应数字分别为122例、10例和23例。研究期间所有接受治疗(手术和非手术)患者的总体5年生存率在拉希队列为7%,在名古屋队列为16%。总体10年生存率分别为0%和12%。切缘阴性的切除患者中,拉希队列的5年和10年生存率分别为43%和0%,名古屋队列为25%和18%。拉希患者的手术死亡率为4%,名古屋患者为8%。在接受切除的患者中,8%的拉希患者和89%的名古屋患者进行了整块尾状叶切除术。切除癌症的组织病理学检查显示,名古屋患者的疾病分期高于拉希患者。
在拉希和名古屋的患者中,肝门部胆管癌切缘阴性切除时生存率最理想。名古屋队列中胆管和肝脏联合切除加尾状叶切除术有助于提高切缘阴性切除率。